Join the 9th Annual
Rosenman Symposium
UCSF Mission Bay Conference Center
May 20-21, 2025
Learn More!
Hear the best and brightest in healthcare share personal stories, career insights, and valuable lessons learned—brought to you by the UCSF Rosenman Institute.
🎧 Listen Now!
ADAPT
Rosenman Institute & Partners Awards $100k
to the 2024 ADAPT Awardees
Bringing together startups & payers/health systems to collaborate & accelerate solutions to market.
Read Press Release!
Rosenman Innovators
Accelerate Your MedTech and Transform Care
Learn More!
We Are Transforming Health Together!
Here’s to ten years of groundbreaking innovation—and our continued drive to shape the future of healthcare, together.
Read More!
Health innovation starts here.
We are an ecosystem of entrepreneurs, industry experts and investors dedicated to improving lives through health technology.
Get in Touch
Championing LGBTQ+ Healthcare Equality
UCSF Health Named 2024 LGBTQ+ Healthcare Equality Leader
Learn More
We empower #Medtech Innovation…
We make getting to market easier for entrepreneurs by offering insider knowledge, mentorship, connections and access to funding.
Get in Touch
…to deliver the future of patient care.
Improving patient lives through innovative technology is our passion and why we do what we do.
Get in Touch
Investors
Get early access to some of the most exciting healthtech innovations happening.
Invest
Entrepreneurs
Learn how our programs, resources and partners can help you at every stage.
Grow
Industry Partners
Bring your expertise and join us in building tomorrow’s healthtech innovations.
Connect
The ecosystem that never sleeps
There’s always a lot of good happening in the Rosenman network — for patients, for entrepreneurs, for investors.
May 08, 2025
UCSF Rosenman RISE Program Welcomes the 2025 Class of Health Innovators From the press release. Supporting bold ideas in healthcare […]
Learn Ira’s innovative vision for a more humane and effective healthcare future.
May 05, 2025
UCSF Rosenman Institute Welcomes Barbara Wachsman to Advisory Board San Francisco, CA, May 2, 2025 — The UCSF Rosenman Institute […]
Collective impact
Helping patients is what drives all of us in the Rosenman community. That takes incredible ideas, access to capital, connections to people who can propel a young brilliant company forward—and an understanding of global regulatory environments.
112542630
Patients Impacted
3014288072
Dollars Raised
Portfolio
The UCSF Rosenman Institute has been supporting transformative health technology companies from concept to commercialization since 2014.
“We are delighted to have the opportunity to work with the key healthcare partners through the ADAPT program, and grateful for the impact the $150,000 grant has had on accelerating our technology development. The ADAPT program has supported Emme in our ability to reach patients more quickly and on a broader scale, which is especially meaningful in the context of the unprecedented demand the past year has shown for women’s digital health support.”
“We’re still benefiting from the connections we made at the Rosenman Innovator program. Some of the advisors, our marketing consultant, some of the really important business and partner relationships that we were introduced to, continue to have value. I expect them to continue to have value for many more years to me and to our company.”
“The Rosenman Innovator Program has been a terrific resource for finding experts to help grow the company at every step: regulatory, clinical, development, legal, and otherwise. The program honed in and focused on critical issues and topics highly relevant to development in diagnostics, devices, and therapeutics.”
“Our experience with the Rosenman ADAPT program was exceptional. From the first step (a reasonably short and to the point application, which is rare for opportunities like these), to the periodic updates as we moved through the stages, to the insights and feedback offered during our pitch opportunities, the value for ConsejoSano in working with the Rosenman Institute has been tangible. We’ve already connected with two large potential health plan clients which I expect will lead to significant revenue opportunities for us. I would recommend the ADAPT program to any healthtech company that is ready to grow on a bigger stage.”
“We have always felt so fortunate to have worked with the UCSF Rosenman Institute. Of the three people they introduced us to, one joined as our COO, one as a director of the board and one as a consultant for six months.”
“I highly recommend entering the ADAPT Program to any innovative startup! Winning a proof-of-concept opportunity with a leading healthcare company via ADAPT 2020 was a pivotal moment for Oshi Health. The clinical study we have launched with our sponsor will prove the value of our virtual-first gastroenterology clinic relative to traditional GI care delivery.”
“The Rosenman Innovator program was a fantastic experience and opportunity to get exposure to seed-stage healthcare investors and other industry stakeholders. We met two investors who participated in our round through the program.”
“The Rosenman Executive Mentorship program introduced us to medtech legends with years of experience, who have created several hundred million dollars in acquisition value in our technology sector.”
“We were matched with Cannon Quality Group, who provided valuable guidance on appropriate quality systems for our stage of development, as well as a roadmap for the future.”
“Through the Rosenman Innovators I was able to meet investors, advisors, and fellow CEOs who helped me both get introduced to investors and navigate the process.
I would recommend the Innovators program to a friend or fellow CEO: it is one of the most accessible friendly welcoming communities that I have found in the medtech space.”
Connect with Rosenman
Science plus social makes for an extra strong network. Join in and join us on social media.
Featured portfolio companies
Check out and connect with these Rosenman portfolio companies.
Oshi Health
Oshi Health is a digital care company revolutionizing the diagnosis, management and treatment of digestive health conditions. Oshi Health was a 2020 ADAPT awardee through the University of California, San Francisco (UCSF) Rosenman Institute.
Learn
more
GT Medical Technologies
GT Medical Technologies is a medical device company with the purpose of “Improving the Lives of Patients with Brain Tumors”. Our GammaTile™ Therapy uses an implantable collagen tile with embedded radio isotope. Over 100 patients (most with recurrent brain tumors) have been treated with GammaTile™ Therapy with impressive results compared to the current standard of care for these patients. The company anticipates FDA clearance in mid-2018 with a limited market release in Q4, 2018, with a goal of establishing the new standard of care.
Learn more
Zeto
For hospitals and clinics dissatisfied with traditional EEG, Zeto offers a turnkey solution for routine EEG tests. Unlike competitors, Zeto provides lower cost and faster turnaround time to clinics, extraordinary convenience to operators and a better experience to patients. Zeto makes EEG available to facilities that do not have access to trained EEG operators or neurologists.
Learn more
